ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
10.00
0.00 (0.00%)
At close: Dec 5, 2025
ZIVO Bioscience Revenue
ZIVO Bioscience had revenue of $65.63K in the quarter ending September 30, 2025, with 108.33% growth. This brings the company's revenue in the last twelve months to $209.03K, up 164.52% year-over-year. In the year 2024, ZIVO Bioscience had annual revenue of $157.22K with 468.61% growth.
Revenue (ttm)
209.03K
Revenue Growth
+164.52%
P/S Ratio
186.41
Revenue / Employee
29.86K
Employees
7
Market Cap
38.96M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
ZIVO Bioscience News
- 2 months ago - Insider Buying: Christopher Maggiore Acquires Additional Shares of Zivo Bioscience Inc (ZIVO) - GuruFocus
- 3 months ago - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses - Business Wire
- 6 months ago - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry - Business Wire
- 7 months ago - University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - Business Wire
- 10 months ago - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Business Wire
- 11 months ago - ZIVO Bioscience to Present at The Microcap Conference 2025 - Business Wire
- 1 year ago - ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Business Wire
- 1 year ago - ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Business Wire